DK1456351T3 - Ny mælkesyrebakteriestamme samt spiselige præparater, lægemidler og veterinærprodukter, der indeholder denne - Google Patents

Ny mælkesyrebakteriestamme samt spiselige præparater, lægemidler og veterinærprodukter, der indeholder denne

Info

Publication number
DK1456351T3
DK1456351T3 DK02805876T DK02805876T DK1456351T3 DK 1456351 T3 DK1456351 T3 DK 1456351T3 DK 02805876 T DK02805876 T DK 02805876T DK 02805876 T DK02805876 T DK 02805876T DK 1456351 T3 DK1456351 T3 DK 1456351T3
Authority
DK
Denmark
Prior art keywords
pharmaceuticals
lactic acid
acid bacteria
products containing
bacteria strain
Prior art date
Application number
DK02805876T
Other languages
Danish (da)
English (en)
Inventor
Simone Claudio De
Original Assignee
Actial Farmaceutica Lda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actial Farmaceutica Lda filed Critical Actial Farmaceutica Lda
Application granted granted Critical
Publication of DK1456351T3 publication Critical patent/DK1456351T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/169—Plantarum
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/21—Streptococcus, lactococcus
    • A23V2400/249—Thermophilus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/529—Infantis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/885—Streptococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
DK02805876T 2001-12-21 2002-12-19 Ny mælkesyrebakteriestamme samt spiselige præparater, lægemidler og veterinærprodukter, der indeholder denne DK1456351T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001RM000763A ITRM20010763A1 (it) 2001-12-21 2001-12-21 Nuovo ceppo di batterio lattico e composizioni commestibili, farmaci e prodotti veterinari che lo contengono.

Publications (1)

Publication Number Publication Date
DK1456351T3 true DK1456351T3 (da) 2006-12-11

Family

ID=11455924

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02805876T DK1456351T3 (da) 2001-12-21 2002-12-19 Ny mælkesyrebakteriestamme samt spiselige præparater, lægemidler og veterinærprodukter, der indeholder denne

Country Status (28)

Country Link
US (2) US7223591B2 (uk)
EP (2) EP1456351B1 (uk)
JP (2) JP4339124B2 (uk)
KR (1) KR100934747B1 (uk)
CN (2) CN100502893C (uk)
AR (1) AR038036A1 (uk)
AT (1) ATE335807T1 (uk)
AU (1) AU2002367124B2 (uk)
BR (1) BR0207397A (uk)
CA (1) CA2457801C (uk)
CY (1) CY1105402T1 (uk)
DE (1) DE60213859T2 (uk)
DK (1) DK1456351T3 (uk)
EA (1) EA006688B1 (uk)
ES (1) ES2271384T3 (uk)
HU (1) HU225787B1 (uk)
IL (2) IL161995A0 (uk)
IS (1) IS2645B (uk)
IT (1) ITRM20010763A1 (uk)
MA (1) MA27685A1 (uk)
MX (1) MXPA03007483A (uk)
NO (1) NO329645B1 (uk)
NZ (1) NZ533696A (uk)
PL (1) PL207395B1 (uk)
PT (1) PT1456351E (uk)
UA (1) UA80546C2 (uk)
WO (1) WO2003055984A1 (uk)
ZA (1) ZA200405763B (uk)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
US8697051B2 (en) * 1999-06-09 2014-04-15 Vsl Pharmaceuticals Inc. Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
ITRM20010763A1 (it) 2001-12-21 2003-06-21 Simone Claudio De Nuovo ceppo di batterio lattico e composizioni commestibili, farmaci e prodotti veterinari che lo contengono.
US20050239706A1 (en) * 2003-10-31 2005-10-27 Washington University In St. Louis Modulation of fiaf and the gastrointestinal microbiota as a means to control energy storage in a subject
US20100047320A1 (en) * 2006-09-07 2010-02-25 Satya Prakash Oral polymeric membrane feruloyl esterase producing bacteria formulation
WO2009090961A1 (ja) * 2008-01-15 2009-07-23 Sapporo Breweries Limited アルコール性肝障害抑制剤
WO2010108865A1 (en) 2009-03-25 2010-09-30 Chr. Hansen A/S Use of probiotics to ameliorate diet-induced insulin resistance
TW201106957A (en) * 2009-08-31 2011-03-01 Synbio Tech Inc The new strain of Lactobacillus plantarum LP28 and its use in treating allergy
CN102702372B (zh) * 2010-10-28 2013-11-27 内蒙古蒙牛乳业（集团）股份有限公司 一种嗜热链球菌胞外多糖及其制备和检测方法
KR101238836B1 (ko) 2011-05-17 2013-03-04 삼육대학교산학협력단 혼합 유산균을 포함하는 비만 또는 비만 관련 질환 치료 또는 예방용 약제학적 조성물 또는 식품 조성물
EP2609814A1 (en) * 2011-12-30 2013-07-03 Nestec S.A. Lactobacillus reuteri DSM 17938 for the development of cognitive function
JP6061530B2 (ja) * 2012-07-25 2017-01-18 株式会社ヤクルト本社 Ｎａｓｈ予防治療剤
CA2885537C (en) 2012-09-20 2021-11-23 Prothera, Inc. Probiotic compositions and methods for the treatment of obesity and obesity-related conditions
KR101545551B1 (ko) 2013-12-12 2015-08-19 주식회사한국야쿠르트 인슐린 저항성 개선 효능을 갖는 7종의 유산균 복합균주를 유효성분으로 함유하는 조성물
KR101426275B1 (ko) 2014-04-04 2014-08-06 주식회사한국야쿠르트 지방합성 억제 및 지방산화 촉진에 의한 체지방 감소 효능을 갖는 5종의 유산균 복합균주를 유효성분으로 함유하는 조성물
EP3165599A4 (en) * 2014-05-29 2017-12-27 Nitto Pharmaceutical Industries, Ltd. Novel lactic acid bacterium and composition including said lactic acid bacterium
EP3172973B1 (en) * 2015-11-27 2020-04-08 DAFLORN Ltd. Probiotic formula, process of its preparation and use
KR20220001516A (ko) * 2016-04-14 2022-01-05 듀폰 뉴트리션 바이오사이언시즈 에이피에스 식품, 에너지 및/또는 지방 섭취 감소를 위한 비피더스균
JP7606276B2 (ja) * 2017-03-22 2024-12-25 雪印メグミルク株式会社 脂質代謝改善用組成物
KR102218992B1 (ko) 2017-12-12 2021-02-23 한국생명공학연구원 아가토바쿨룸 속 균주를 유효성분으로 함유하는 자폐 범주성 장애의 예방, 개선 또는 치료용 조성물
KR102021881B1 (ko) * 2018-09-07 2019-09-17 재단법인 전남생물산업진흥원 스트렙토코커스 써모필러스 lm1012 균주 및 이를 포함하는 염증 질환 또는 대사 질환의 예방 또는 치료용 조성물
CN113025527A (zh) * 2021-03-25 2021-06-25 上海市第十人民医院 一种用来预测婴幼儿肥胖病的乳源性唾液链球菌及其分离方法
JP7849997B2 (ja) * 2022-03-29 2026-04-22 雪印メグミルク株式会社 Ｉａｐ活性化用組成物
CN115181698B (zh) * 2022-06-28 2023-09-08 广东粤港澳大湾区国家纳米科技创新研究院 一种益生菌组合物及应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61221124A (ja) * 1985-03-26 1986-10-01 Advance Res & Dev Co Ltd 肝機能改善剤
US5716615A (en) * 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
US6297229B1 (en) * 1994-11-14 2001-10-02 Mayo Foundation For Medical Education And Research Use of ursodeoxycholic acid to treat nonalcoholic steatohepatitis
US5760010A (en) * 1995-01-01 1998-06-02 Klein; Ira Method of treating liver disorders with a macrolide antibiotic
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
MY117168A (en) * 1997-12-05 2004-05-31 Viva America Marketing Inc Composition and method for treating nonalcoholic steatohepatitis
IT1298918B1 (it) * 1998-02-20 2000-02-07 Mendes Srl Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
IT1309427B1 (it) * 1999-05-28 2002-01-23 Mendes S U R L Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso
ITRM20010763A1 (it) 2001-12-21 2003-06-21 Simone Claudio De Nuovo ceppo di batterio lattico e composizioni commestibili, farmaci e prodotti veterinari che lo contengono.

Also Published As

Publication number Publication date
US7223591B2 (en) 2007-05-29
CA2457801A1 (en) 2003-07-10
AU2002367124A1 (en) 2003-07-15
AR038036A1 (es) 2004-12-22
CN100502893C (zh) 2009-06-24
HUP0402460A3 (en) 2005-04-28
JP2009183296A (ja) 2009-08-20
EA006688B1 (ru) 2006-02-24
BR0207397A (pt) 2004-02-10
ES2271384T3 (es) 2007-04-16
UA80546C2 (en) 2007-10-10
MA27685A1 (fr) 2006-01-02
ITRM20010763A1 (it) 2003-06-21
DE60213859T2 (de) 2007-02-08
KR100934747B1 (ko) 2009-12-30
IL161995A (en) 2010-11-30
JP2005512590A (ja) 2005-05-12
IS2645B (is) 2010-08-15
HK1100165A1 (zh) 2007-09-07
MXPA03007483A (es) 2003-12-04
CY1105402T1 (el) 2010-04-28
ATE335807T1 (de) 2006-09-15
DE60213859D1 (de) 2006-09-21
CN1875994A (zh) 2006-12-13
ZA200405763B (en) 2006-07-26
NZ533696A (en) 2005-12-23
WO2003055984A1 (en) 2003-07-10
AU2002367124B2 (en) 2007-11-29
EA200400845A1 (ru) 2004-12-30
EP1456351B1 (en) 2006-08-09
HUP0402460A2 (hu) 2005-03-29
NO20033621D0 (no) 2003-08-14
PT1456351E (pt) 2006-10-31
JP4339124B2 (ja) 2009-10-07
US7628981B2 (en) 2009-12-08
HU225787B1 (hu) 2007-09-28
US20070253934A1 (en) 2007-11-01
US20040248278A1 (en) 2004-12-09
HK1072958A1 (en) 2005-09-16
IL161995A0 (en) 2005-11-20
NO20033621L (no) 2003-08-14
PL207395B1 (pl) 2010-12-31
CN1276970C (zh) 2006-09-27
KR20040074053A (ko) 2004-08-21
EP1652913A1 (en) 2006-05-03
NO329645B1 (no) 2010-11-22
EP1456351A1 (en) 2004-09-15
CN1558946A (zh) 2004-12-29
IS7229A (is) 2004-04-21
CA2457801C (en) 2013-06-04
PL370252A1 (en) 2005-05-16

Similar Documents

Publication Publication Date Title
DK1456351T3 (da) Ny mælkesyrebakteriestamme samt spiselige præparater, lægemidler og veterinærprodukter, der indeholder denne
DK1284103T3 (da) Modificerede majsgrynprodukter samt fremgangsmåde
DK1498039T3 (da) Vitale cellepræparater, som indeholder mælkesyrebakterie som aktivt stof, og mælkesyrebakterieholdige fødevareprodukter
IL233223A (en) Pharmaceutical and diagnostic compositions containing nucleic acids and corresponding proteins entitled 282p1g3
NO20042694L (no) 17 alfa-alkyl-17 beta-oksy-ostratriener og mellomprodukter for fremstilling av disse, anvendelse av 17 alfa-alkyl-17 beta-oksy-ostratrienene til fremstilling av legemidler samt farmasoytiske preparater
SI1572707T1 (sl) Novi aromatski fluorglikozidni derivati, farmacevtski proizvodi, ki vsebujejo te spojine, in njihova uporaba
NO20013736D0 (no) Pyrazolkarboksylsyrederivater, deres fremstilling og farmasöytiske preparater inneholdende de samme
AU1030501A (en) Microcapsules for stabilizing cosmetic, pharmaceutical or food products
IL161268A0 (en) Nucleic acid and corresponding protein entitled 161p2f10b and pharmaceutical and diagnostic compositions containing the same
MXPA03008775A (es) Productos y metodos para mejorar la higiene dental animal.
NO20055335D0 (no) Preparater og fremgangsmate for formulering av enteralformuleringer inneholdende sialsyre
DK1458856T3 (da) Isolerede fager og deres anvendelse i fødevare- eller kæledyrsfoderprodukter
GB0207267D0 (en) Wheel measuring system,wheel measuring method and wheel related product sales method
ITTO20021009A1 (it) Procedimento, sistema e prodotto informatico per la
NO20020374L (no) Karboksylsyreamider, medikamenter inneholdende disse forbindelser, deres anvendelse og fremstilling
ITRM20020476A0 (it) Procedimento e sistema di configurazione di prodotti.
FI20030287L (fi) Polydekstroosin uusi käyttö syötävässä tuotteessa polydekstroosia sisältävät syötävät tuotteet ja menetelmät polydekstroosin sisällyttämiseksi syötäviin tuotteisiin
DE60228111D1 (de) Difluoralkenderivat, dieses enthaltende mittel zur bekämpfung von schädlingen und zwischenprodukt dafür
IL158293A0 (en) Nucleic acid and corresponding protein entitled 158p3d2 and pharmaceutical compositions containing the same
FI20010566L (fi) Tiedonsiirtomenetelmä, -järjestelmä ja ohjelmatuote
BR0310126B1 (pt) mÉtodo de conservaÇço de produto de madeira, e produto de madeira tendo propriedades inseticidas/acaricidas.
NO20032959L (no) Derivater av etoposid og analoger, samt farmasöytiske preparater inneholdende disse
IL160651A0 (en) Nucleic acid and correspondidng protein entitled 205pib5 and pharmaceutical compositions containing the same
SI1456351T1 (sl) Nova sev mlecnokislinske bakterije in uzitne zmesi, zdravila in veterinarski proizvodi, ki jo vsebujejo
AU2002258548A1 (en) Identification of the ikappabns protein and its products